Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AVA

Leukotriene A4 hydrolase in complex with 4-(4-benzylphenyl)-oxazol-2-amine

8AVA の概要
エントリーDOI10.2210/pdb8ava/pdb
関連するPDBエントリー4L2L
分子名称Leukotriene A-4 hydrolase, ZINC ION, YTTERBIUM (III) ION, ... (8 entities in total)
機能のキーワードleukotriene b4, inflammation, inhibitor, complex, immune system
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計71759.25
構造登録者
Teder, T.,Haeggstrom, J.Z. (登録日: 2022-08-26, 公開日: 2023-05-03, 最終更新日: 2024-02-07)
主引用文献Teder, T.,Konig, S.,Singh, R.,Samuelsson, B.,Werz, O.,Garscha, U.,Haeggstrom, J.Z.
Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A 4 Hydrolase.
Int J Mol Sci, 24:-, 2023
Cited by
PubMed Abstract: The 5-lipoxygenase (5-LOX) pathway gives rise to bioactive inflammatory lipid mediators, such as leukotrienes (LTs). 5-LOX carries out the oxygenation of arachidonic acid to the 5-hydroperoxy derivative and then to the leukotriene A epoxide which is converted to a chemotactic leukotriene B (LTB) by leukotriene A hydrolase (LTAH). In addition, LTAH possesses aminopeptidase activity to cleave the N-terminal proline of a pro-inflammatory tripeptide, prolyl-glycyl-proline (PGP). Based on the structural characteristics of LTAH, it is possible to selectively inhibit the epoxide hydrolase activity while sparing the inactivating, peptidolytic, cleavage of PGP. In the current study, chalcogen-containing compounds, 4-(4-benzylphenyl) thiazol-2-amine (ARM1) and its selenazole (TTSe) and oxazole (TTO) derivatives were characterized regarding their inhibitory and binding properties. All three compounds selectively inhibit the epoxide hydrolase activity of LTAH at low micromolar concentrations, while sparing the aminopeptidase activity. These inhibitors also block the 5-LOX activity in leukocytes and have distinct inhibition constants with recombinant 5-LOX. Furthermore, high-resolution structures of LTAH with inhibitors were determined and potential binding sites to 5-LOX were proposed. In conclusion, we present chalcogen-containing inhibitors which differentially target essential steps in the biosynthetic route for LTB and can potentially be used as modulators of inflammatory response by the 5-LOX pathway.
PubMed: 37108702
DOI: 10.3390/ijms24087539
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.354 Å)
構造検証レポート
Validation report summary of 8ava
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon